NL7706064A - Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten. - Google Patents
Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.Info
- Publication number
- NL7706064A NL7706064A NL7706064A NL7706064A NL7706064A NL 7706064 A NL7706064 A NL 7706064A NL 7706064 A NL7706064 A NL 7706064A NL 7706064 A NL7706064 A NL 7706064A NL 7706064 A NL7706064 A NL 7706064A
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- components
- active component
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2287776 | 1976-06-03 | ||
GB5034076 | 1976-12-02 | ||
GB1214577 | 1977-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7706064A true NL7706064A (nl) | 1977-12-06 |
Family
ID=27256793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7706064A NL7706064A (nl) | 1976-06-03 | 1977-06-02 | Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten. |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS52151168A (xx) |
CA (1) | CA1176261A (xx) |
CH (3) | CH645631A5 (xx) |
DE (1) | DE2724948A1 (xx) |
DK (1) | DK244577A (xx) |
ES (5) | ES459412A1 (xx) |
FI (1) | FI71930C (xx) |
FR (1) | FR2362839A1 (xx) |
HU (1) | HU183046B (xx) |
NL (1) | NL7706064A (xx) |
NZ (1) | NZ184281A (xx) |
SE (2) | SE446336B (xx) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002259A2 (en) * | 1977-12-01 | 1979-06-13 | The Wellcome Foundation Limited | Hydantoin derivatives and salts thereof, their synthesis and pharmaceutical formulations |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1602188A (en) * | 1977-12-01 | 1981-11-11 | Wellcome Found | Hydantoin derivatives |
IE48747B1 (en) * | 1977-09-05 | 1985-05-15 | Wellcome Found | Hydantoin derivatives |
EP0003410B1 (en) * | 1978-01-23 | 1982-10-06 | Beecham Group Plc | Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them |
EP0004723A1 (en) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them |
GB1599740A (en) * | 1978-05-31 | 1981-10-07 | Wellcome Found | Hydantoin derivatives |
US4294972A (en) * | 1978-06-15 | 1981-10-13 | Beecham Group Limited | 1,2-Disubstituted oxo triazolidine |
AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
EP0006352A1 (en) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them |
IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
IL59065A0 (en) | 1979-01-18 | 1980-05-30 | Beecham Group Ltd | Hydantoin derivatives,their preparation pharmaceutical compositons containing them |
GB2050371A (en) * | 1979-05-09 | 1981-01-07 | Wellcome Found | Optically active hydantoin derivatives and pharmaceutical formulations containing them |
US4684735A (en) * | 1985-07-01 | 1987-08-04 | Stauffer Chemical Company | Promotion of raney nickel hydrogenation catalyst |
JP3022878U (ja) * | 1995-08-18 | 1996-04-02 | 有限会社春江加工 | ミニディスク用ケース |
CN1582279A (zh) | 2001-11-30 | 2005-02-16 | 伊莱利利公司 | 过氧化物酶体激活的受体激动剂 |
US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
JP2006527189A (ja) * | 2003-06-06 | 2006-11-30 | アラーガン、インコーポレイテッド | ピペリジニルプロスタグランジンe類似体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1524818A (en) * | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-06-02 FR FR7716849A patent/FR2362839A1/fr active Granted
- 1977-06-02 FI FI771763A patent/FI71930C/fi not_active IP Right Cessation
- 1977-06-02 NZ NZ184281A patent/NZ184281A/xx unknown
- 1977-06-02 HU HU77WE560A patent/HU183046B/hu unknown
- 1977-06-02 DE DE19772724948 patent/DE2724948A1/de not_active Ceased
- 1977-06-02 JP JP6525277A patent/JPS52151168A/ja active Granted
- 1977-06-02 DK DK244577A patent/DK244577A/da not_active Application Discontinuation
- 1977-06-02 NL NL7706064A patent/NL7706064A/xx not_active Application Discontinuation
- 1977-06-02 ES ES459412A patent/ES459412A1/es not_active Expired
- 1977-06-02 SE SE7706428A patent/SE446336B/xx unknown
- 1977-06-02 CH CH679677A patent/CH645631A5/de not_active IP Right Cessation
- 1977-06-02 CA CA000280455A patent/CA1176261A/en not_active Expired
-
1978
- 1978-06-01 ES ES470428A patent/ES470428A1/es not_active Expired
-
1979
- 1979-02-28 ES ES478156A patent/ES478156A1/es not_active Expired
- 1979-06-28 ES ES482010A patent/ES482010A1/es not_active Expired
-
1980
- 1980-03-25 ES ES489883A patent/ES8103057A1/es not_active Expired
-
1982
- 1982-05-19 SE SE8203161A patent/SE8203161L/sv not_active Application Discontinuation
-
1984
- 1984-02-07 CH CH57784A patent/CH646426A5/de not_active IP Right Cessation
- 1984-02-07 CH CH576/84A patent/CH647511A5/de not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002259A2 (en) * | 1977-12-01 | 1979-06-13 | The Wellcome Foundation Limited | Hydantoin derivatives and salts thereof, their synthesis and pharmaceutical formulations |
EP0002259A3 (en) * | 1977-12-01 | 1979-06-27 | The Wellcome Foundation Limited | Hydantoin derivatives and salts thereof, their synthesis and intermediates, and pharmaceutical formulations |
Also Published As
Publication number | Publication date |
---|---|
FR2362839B1 (xx) | 1980-02-01 |
ES489883A0 (es) | 1981-02-16 |
HU183046B (en) | 1984-04-28 |
ES478156A1 (es) | 1979-11-01 |
JPS6222986B2 (xx) | 1987-05-20 |
ES8103057A1 (es) | 1981-02-16 |
SE446336B (sv) | 1986-09-01 |
FI71930B (fi) | 1986-11-28 |
FI71930C (fi) | 1987-03-09 |
FI771763A (fi) | 1977-12-04 |
SE7706428L (sv) | 1977-12-04 |
FR2362839A1 (fr) | 1978-03-24 |
DK244577A (da) | 1977-12-04 |
CH647511A5 (en) | 1985-01-31 |
NZ184281A (en) | 1980-04-28 |
CH645631A5 (en) | 1984-10-15 |
CA1176261A (en) | 1984-10-16 |
DE2724948A1 (de) | 1977-12-15 |
JPS52151168A (en) | 1977-12-15 |
ES482010A1 (es) | 1980-08-16 |
ES470428A1 (es) | 1979-09-01 |
CH646426A5 (en) | 1984-11-30 |
SE8203161L (sv) | 1982-05-19 |
ES459412A1 (es) | 1978-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7714329A (nl) | Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7708741A (nl) | Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. | |
NL7507268A (nl) | Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten. | |
NL7702548A (nl) | Werkwijze ter bereiding van 3,7-digesubstitueerde- -3-cefem-4-carbonzuurverbindingen, alsmede farma- ceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7603193A (nl) | Werkwijze ter bereiding van acyclische, alicycli- sche en aromatische n-gesubstitueerde halogeen-2- -pyrrolidinonen met herbicidewerking alsmede her- bicidepreparaten die deze verbindingen als actie- ve component bevatten. | |
NL7709697A (nl) | Werkwijze ter bereiding van thiazolidinederivaten, alsmede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten. | |
NL7706064A (nl) | Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten. | |
NL7700379A (nl) | Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7713470A (nl) | Werkwijze ter bereiding van 2-gesubstitueerde benzimidazoolverbindingen en de zuuradditiezou- ten daarvan alsmede farmaceutische preparaten die deze verbindingen als actieve component be- vatten. | |
BE857181A (nl) | Werkwijze ter bereiding van n-alkynyl-&-(gesugstitueerde fenoxy) alkylamiden met herbicidewerking alsmede herbicide-preparaten die deze verbindingen als actieve component bevatten | |
NL7610480A (nl) | Werkwijze ter bereiding van hypolipemische ver- bindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7607337A (nl) | Werkwijze ter bereiding van spirocycloalkyl- prostaanzuren en derivaten daarvan, alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten. | |
NL7604797A (nl) | Werkwijze ter bereiding van nieuwe antibacteriele middelen alsmede preparaten die deze verbindingen als actieve component bevatten. | |
NL7609559A (nl) | Werkwijze ter bereiding van oxazolidinonen alsmede geneeskrachtige middelen die deze ver- bindingen als actieve component bevatten. | |
NL7607975A (nl) | Werkwijze ter bereiding van difenylsulfiden alsmede farmaceutische preparaten die deze verbindingen als actieve component omvatten. | |
NL7702180A (nl) | Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7708982A (nl) | Werkwijze ter bereiding van dihydro-oxo-nicotine- zuren, alsmede farmaceutische preparaten die de- ze verbinding als actieve component bevatten. | |
NL7711414A (nl) | Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7707150A (nl) | Werkwijze ter bereiding van 2-lagere alkyl-7-ge- substitueerde-2 of 3-cefem-4-carbonzuurverbin- dingen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
NL7613041A (nl) | Werkwijze ter bereiding van picolinezuurderiva- ten alsmede preparaten die deze verbindingen als actieve component omvatten. | |
NL7714063A (nl) | Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten. | |
NL7412302A (nl) | Werkwijze ter bereiding van pyrazoliumverbindin- gen, alsmede herbicide preparaten die deze ver- bindingen als actieve component bevatten. | |
NL7607494A (nl) | Werkwijze ter bereiding van 2-benzopyranonderi- vaten alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten. | |
NL7613334A (nl) | Werkwijze ter bereiding van carbamaat-sulfenyl- -carbamoylfluorideverbindingen, alsmede pestici- de preparaten die deze verbindingen als actieve component omvatten. | |
NL7709092A (nl) | Werkwijze ter bereiding van cefalosporinever- bindingen met antibacteriele activiteit als- mede farmaceutische preparaten die deze ver- bindingen als actieve component bevatten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
A85 | Still pending on 85-01-01 | ||
BC | A request for examination has been filed | ||
BV | The patent application has lapsed |